Development of a Nanoparticle-Based Approach for the Blood-Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis.
Nanomedicine
amyotrophic lateral sclerosis
blood–brain barrier
pharmacology
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
10 12 2022
10 12 2022
Historique:
received:
07
11
2022
revised:
06
12
2022
accepted:
08
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
27
12
2022
Statut:
epublish
Résumé
The development of nanoparticles (NPs) to enable the passage of drugs across blood-brain barrier (BBB) represents one of the main challenges in neuropharmacology. In recent years, NPs that are able to transport drugs and interact with brain endothelial cells have been tested. Here, we investigated whether the functionalization of avidin-nucleic-acid-nanoassembly (ANANAS) with apolipoprotein E (ApoE) would allow BBB passage in the SOD1
Identifiants
pubmed: 36552768
pii: cells11244003
doi: 10.3390/cells11244003
pmc: PMC9776960
pii:
doi:
Substances chimiques
Superoxide Dismutase-1
EC 1.15.1.1
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Brain. 2015 Apr;138(Pt 4):974-91
pubmed: 25678563
ACS Nano. 2018 Jul 24;12(7):7292-7300
pubmed: 29953205
Mater Today Bio. 2020 May 04;6:100055
pubmed: 32529183
Front Pharmacol. 2021 May 26;12:683935
pubmed: 34122112
Cell Mol Neurobiol. 2001 Jun;21(3):237-54
pubmed: 11569536
Nat Neurosci. 2008 Apr;11(4):420-2
pubmed: 18344992
Acta Neuropathol Commun. 2014 Jun 13;2:66
pubmed: 24923195
Neurobiol Dis. 2020 Jun;139:104815
pubmed: 32087285
NeuroRx. 2005 Jan;2(1):3-14
pubmed: 15717053
Nanomedicine. 2022 Feb;40:102497
pubmed: 34838993
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):242-249
pubmed: 29308669
Bioconjug Chem. 2010 Jul 21;21(7):1254-63
pubmed: 20527874
Adv Sci (Weinh). 2021 Jun;8(11):e2002085
pubmed: 34105297
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(7-8):584-592
pubmed: 32627599
Acta Neurol Scand. 1990 Aug;82(2):132-4
pubmed: 2256442
Neuron. 2009 Aug 13;63(3):287-303
pubmed: 19679070
Neurotherapeutics. 2015 Apr;12(2):461-76
pubmed: 25761970
Neurobiol Dis. 2012 Aug;47(2):194-200
pubmed: 22521463
Anal Biochem. 1980 Sep 1;107(1):60-3
pubmed: 7435960
J Mol Med (Berl). 2006 Jan;84(1):29-36
pubmed: 16292665
ACS Nano. 2014 Jan 28;8(1):175-87
pubmed: 24328174
J Mol Recognit. 2004 Nov-Dec;17(6):558-66
pubmed: 15386619
ACS Nano. 2019 Apr 23;13(4):4410-4423
pubmed: 30883091
PLoS One. 2007 Nov 21;2(11):e1205
pubmed: 18030339
Front Mol Neurosci. 2017 Apr 06;10:99
pubmed: 28428745
Front Cell Neurosci. 2014 Feb 03;8:21
pubmed: 24550780
Epilepsia. 2012 Nov;53 Suppl 6:45-52
pubmed: 23134495
Biomaterials. 2013 Dec;34(36):9171-82
pubmed: 24008043
Nat Commun. 2018 Oct 4;9(1):4070
pubmed: 30287819
Small. 2013 May 27;9(9-10):1521-32
pubmed: 23019091
J Pharm Biomed Anal. 2007 Jan 4;43(1):376-80
pubmed: 16887316
Nanomedicine. 2011 Oct;7(5):551-9
pubmed: 21658472
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1305-15
pubmed: 27174096
Biomed Chromatogr. 2015 Apr;29(4):578-83
pubmed: 25165023
Adv Protein Chem. 1975;29:85-133
pubmed: 237414
J Neurosci. 2017 Feb 8;37(6):1413-1427
pubmed: 28011744